OpiCalc

About

Urology

Urology tools include prostate cancer risk models, staging for urologic malignancies, and functional scores for lower urinary tract symptoms (IPSS).

Covered Areas

Prostate Cancer Risk & Staging
Renal Stone Decision Support
Urologic Oncology Staging
Functional Bladder & Voiding Scores

All tools are based on published clinical evidence. Results should be interpreted alongside individual patient presentation and current institutional guidelines.

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

Non-Custodial

bedside-Ready

Resources

About Us Editorial Policy Medical Disclaimer Privacy Policy Terms of Use Cookie Policy

Support

Contact Us

Response time:
Typically < 24 hours.

Clinical Notice:Calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for professional clinical judgment. OpiCalc is an auxiliary reference tool for qualified healthcare professionals.

•

Validated • Peer-Reviewed • Instant

Institutional Registry

Urology

PSA kinetics, prostate cancer staging, and stone risk models.

Tool Suite

Validated Registry

Evidence-based

BPH Impact Index

Bosniak Classification

CAPRA Score

D'Amico Risk Classification

EAU NMIBC Risk Groups (2021)

EORTC Risk Tables for NMIBC

Fournier's Gangrene Severity Index

GUPI (Genitourinary Pain Index)

Guy's Stone Score

ICIQ-UI SF

IGCCCG Classification

IIEF-5 / SHIM

IIQ-7

IMDC (Heng) Risk Criteria

IPSS Score

NIH-CPSI

OAB-V8

PADUA Prediction Score

PI-RADS v2.1

PSA Density

R.E.N.A.L. Nephrometry Score

Residual Volume (PVR)

S.T.O.N.E. Nephrolithometry

SFU Hydronephrosis Grading

UDI-6

VUR Grading

About

Urology

Urology tools include prostate cancer risk models, staging for urologic malignancies, and functional scores for lower urinary tract symptoms (IPSS).

Covered Areas

Prostate Cancer Risk & Staging
Renal Stone Decision Support
Urologic Oncology Staging
Functional Bladder & Voiding Scores

All tools are based on published clinical evidence. Results should be interpreted alongside individual patient presentation and current institutional guidelines.